| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ATF7 ZNF384 SP1 SP3 ZNF280C ZNF507 WT1 ZBTB9 ZNF280B E4F1 ZNF236 ZNF260 ZNF711 TBX18 SAFB ZBTB39 SALL2 WIZ SMARCA4 ZFHX2 SP5 PLAG1 KLF17 | 1.63e-08 | 1244 | 96 | 23 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ATF7 ZNF384 SP1 SP3 ZNF280C ZNF507 WT1 ZBTB9 ZNF280B E4F1 ZNF236 ZNF260 ZNF711 TBX18 SAFB ZBTB39 SALL2 WIZ SMARCA4 ZFHX2 SP5 PLAG1 KLF17 | 2.43e-08 | 1271 | 96 | 23 | GO:0000987 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ZNF438 ATF7 ZNF384 SP1 SP3 ZNF280C ZNF507 WT1 ZBTB9 ZNF280B E4F1 ZNF236 ZNF260 ZNF711 RLF TBX18 ZBTB39 SALL2 WIZ ZNF451 ZFHX2 SP5 PLAG1 KLF17 | 3.71e-08 | 1412 | 96 | 24 | GO:0000981 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ATF7 ZNF384 SP1 SP3 ZNF280C ZNF507 WT1 ZBTB9 ZNF280B E4F1 ZNF236 ZNF260 ZNF711 TBX18 SAFB ZBTB39 SALL2 WIZ SMARCA4 ZFHX2 SP5 PLAG1 KLF17 | 2.96e-07 | 1459 | 96 | 23 | GO:0000977 |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 3.70e-04 | 127 | 96 | 5 | GO:0008094 | |
| GeneOntologyMolecularFunction | microtubule binding | 7.16e-04 | 308 | 96 | 7 | GO:0008017 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 7.43e-04 | 37 | 96 | 3 | GO:0140658 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | 8.96e-04 | 320 | 96 | 7 | GO:0001227 | |
| GeneOntologyMolecularFunction | helicase activity | 9.97e-04 | 158 | 96 | 5 | GO:0004386 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | 9.98e-04 | 326 | 96 | 7 | GO:0001217 | |
| GeneOntologyMolecularFunction | cAMP response element binding | 1.46e-03 | 12 | 96 | 2 | GO:0035497 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 1.67e-03 | 262 | 96 | 6 | GO:0140097 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | NRAP KIF27 CENPE SYNE1 COBLL1 CEP290 LRRK2 LMTK2 FHOD3 CCDC66 KIF15 TIAM1 FGD4 | 2.28e-03 | 1099 | 96 | 13 | GO:0008092 |
| GeneOntologyMolecularFunction | protein kinase A binding | 2.74e-03 | 58 | 96 | 3 | GO:0051018 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | KIF27 CENPE CFTR SMARCAD1 KIF15 SUPV3L1 SMARCA2 SMARCA4 ASCC3 | 2.79e-03 | 614 | 96 | 9 | GO:0140657 |
| GeneOntologyMolecularFunction | C2H2 zinc finger domain binding | 2.97e-03 | 17 | 96 | 2 | GO:0070742 | |
| GeneOntologyMolecularFunction | tubulin binding | 4.59e-03 | 428 | 96 | 7 | GO:0015631 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 4.67e-03 | 70 | 96 | 3 | GO:0003777 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 4.67e-03 | 140 | 96 | 4 | GO:0001221 | |
| Domain | ZINC_FINGER_C2H2_2 | ZNF438 ATF7 ZNF384 SP1 SP3 APTX ZNF280C ZNF507 WT1 ZBTB9 ZNF407 ZNF280B E4F1 ZNF236 ZNF804A ZXDA ZNF260 ZNF711 RLF ZBTB39 SALL2 WIZ ZNF451 ZFHX2 SP5 PLAG1 KLF17 | 8.18e-16 | 775 | 95 | 27 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF438 ATF7 ZNF384 SP1 SP3 APTX ZNF280C ZNF507 WT1 ZBTB9 ZNF407 ZNF280B E4F1 ZNF236 ZNF804A ZXDA ZNF260 ZNF711 RLF ZBTB39 SALL2 WIZ ZNF451 ZFHX2 SP5 PLAG1 KLF17 | 8.72e-16 | 777 | 95 | 27 | PS00028 |
| Domain | Znf_C2H2-like | ZNF438 ATF7 ZNF384 SP1 SP3 APTX ZNF280C ZNF507 WT1 ZBTB9 ZNF407 ZNF280B E4F1 ZNF236 ZNF804A ZXDA ZNF260 ZNF711 RLF ZBTB39 SALL2 WIZ ZNF451 ZFHX2 SP5 PLAG1 KLF17 | 1.58e-15 | 796 | 95 | 27 | IPR015880 |
| Domain | Znf_C2H2 | ZNF438 ATF7 ZNF384 SP1 SP3 APTX ZNF280C ZNF507 WT1 ZBTB9 ZNF407 ZNF280B E4F1 ZNF236 ZNF804A ZXDA ZNF260 ZNF711 RLF ZBTB39 SALL2 WIZ ZNF451 ZFHX2 SP5 PLAG1 KLF17 | 2.08e-15 | 805 | 95 | 27 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF438 ATF7 ZNF384 SP1 SP3 APTX ZNF280C ZNF507 WT1 ZBTB9 ZNF407 ZNF280B E4F1 ZNF236 ZNF804A ZXDA ZNF260 ZNF711 RLF ZBTB39 SALL2 WIZ ZNF451 ZFHX2 SP5 PLAG1 KLF17 | 2.28e-15 | 808 | 95 | 27 | SM00355 |
| Domain | - | ZNF438 ATF7 ZNF384 SP1 SP3 ZNF507 WT1 ZBTB9 ZNF407 E4F1 ZNF236 ZXDA ZNF260 ZNF711 RLF ZBTB39 SALL2 ZFHX2 SP5 PLAG1 KLF17 | 2.13e-11 | 679 | 95 | 21 | 3.30.160.60 |
| Domain | zf-C2H2 | ZNF438 ATF7 ZNF384 SP1 SP3 ZNF507 WT1 ZBTB9 ZNF407 E4F1 ZNF236 ZXDA ZNF260 ZNF711 RLF ZBTB39 SALL2 ZNF451 ZFHX2 SP5 KLF17 | 3.11e-11 | 693 | 95 | 21 | PF00096 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF438 ATF7 ZNF384 SP1 SP3 ZNF507 WT1 ZBTB9 ZNF407 E4F1 ZNF236 ZXDA ZNF260 ZNF711 RLF ZBTB39 SALL2 ZFHX2 SP5 PLAG1 KLF17 | 3.20e-11 | 694 | 95 | 21 | IPR013087 |
| Domain | Sp1_fam | 1.49e-05 | 10 | 95 | 3 | IPR030450 | |
| Domain | SnAC | 2.56e-05 | 2 | 95 | 2 | SM01314 | |
| Domain | Gln-Leu-Gln_QLQ | 2.56e-05 | 2 | 95 | 2 | IPR014978 | |
| Domain | SnAC | 2.56e-05 | 2 | 95 | 2 | IPR029295 | |
| Domain | SnAC | 2.56e-05 | 2 | 95 | 2 | PF14619 | |
| Domain | QLQ | 2.56e-05 | 2 | 95 | 2 | SM00951 | |
| Domain | QLQ | 2.56e-05 | 2 | 95 | 2 | PS51666 | |
| Domain | QLQ | 2.56e-05 | 2 | 95 | 2 | PF08880 | |
| Domain | HSA | 1.53e-04 | 4 | 95 | 2 | SM00573 | |
| Domain | DUF4195 | 1.53e-04 | 4 | 95 | 2 | PF13836 | |
| Domain | HSA | 1.53e-04 | 4 | 95 | 2 | PS51204 | |
| Domain | HSA_dom | 1.53e-04 | 4 | 95 | 2 | IPR014012 | |
| Domain | DUF4195 | 1.53e-04 | 4 | 95 | 2 | IPR025243 | |
| Domain | HSA | 1.53e-04 | 4 | 95 | 2 | PF07529 | |
| Domain | Helicase_C | 2.16e-04 | 107 | 95 | 5 | PF00271 | |
| Domain | HELICc | 2.16e-04 | 107 | 95 | 5 | SM00490 | |
| Domain | Helicase_C | 2.26e-04 | 108 | 95 | 5 | IPR001650 | |
| Domain | HELICASE_CTER | 2.36e-04 | 109 | 95 | 5 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 2.36e-04 | 109 | 95 | 5 | PS51192 | |
| Domain | BRK | 3.79e-04 | 6 | 95 | 2 | SM00592 | |
| Domain | BRK_domain | 3.79e-04 | 6 | 95 | 2 | IPR006576 | |
| Domain | BRK | 3.79e-04 | 6 | 95 | 2 | PF07533 | |
| Domain | SNF2_N | 5.68e-04 | 32 | 95 | 3 | IPR000330 | |
| Domain | SNF2_N | 5.68e-04 | 32 | 95 | 3 | PF00176 | |
| Domain | Kinesin-like_fam | 1.36e-03 | 43 | 95 | 3 | IPR027640 | |
| Domain | KINESIN_MOTOR_1 | 1.45e-03 | 44 | 95 | 3 | PS00411 | |
| Domain | - | 1.45e-03 | 44 | 95 | 3 | 3.40.850.10 | |
| Domain | Kinesin_motor_dom | 1.45e-03 | 44 | 95 | 3 | IPR001752 | |
| Domain | Kinesin | 1.45e-03 | 44 | 95 | 3 | PF00225 | |
| Domain | KINESIN_MOTOR_2 | 1.45e-03 | 44 | 95 | 3 | PS50067 | |
| Domain | KISc | 1.45e-03 | 44 | 95 | 3 | SM00129 | |
| Domain | SSD | 1.93e-03 | 13 | 95 | 2 | IPR000731 | |
| Domain | SSD | 1.93e-03 | 13 | 95 | 2 | PS50156 | |
| Domain | DEXDc | 2.32e-03 | 109 | 95 | 4 | SM00487 | |
| Domain | Helicase_ATP-bd | 2.40e-03 | 110 | 95 | 4 | IPR014001 | |
| Domain | P-loop_NTPase | KIF27 CENPE CFTR LRRK2 SMARCAD1 TRANK1 KIF15 SUPV3L1 SMARCA2 SMARCA4 ASCC3 | 3.82e-03 | 848 | 95 | 11 | IPR027417 |
| Pathway | BIOCARTA_TERT_PATHWAY | 2.06e-06 | 7 | 56 | 3 | MM1541 | |
| Pathway | BIOCARTA_TERT_PATHWAY | 3.28e-06 | 8 | 56 | 3 | M22015 | |
| Pathway | WP_ESTRADIOL_REGULATION_IN_PORTOSINUSOIDAL_VASCULAR_DISEASE | 1.54e-04 | 5 | 56 | 2 | M45554 | |
| Pathway | BIOCARTA_TERC_PATHWAY | 2.30e-04 | 6 | 56 | 2 | MM1564 | |
| Pathway | BIOCARTA_TERC_PATHWAY | 2.30e-04 | 6 | 56 | 2 | M22047 | |
| Pubmed | ZNF438 ATF7 SP1 SP3 NRAP ZNF280C ZNF507 WT1 ZNF280B ZNF236 ZNF260 WIZ ZNF451 SMARCA2 PLAG1 KLF17 KAT6B | 9.45e-11 | 808 | 97 | 17 | 20412781 | |
| Pubmed | 4.82e-10 | 102 | 97 | 8 | 11214970 | ||
| Pubmed | GAPVD1 ERC1 ZNF507 ZBTB9 RNF40 GREB1L RLF SALL2 WIZ KIF15 ASCC3 | 2.61e-08 | 418 | 97 | 11 | 34709266 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | ATF7 ZNF384 SP1 SP3 WT1 E4F1 ZNF236 ZNF711 TBX18 SALL2 ZNF451 ZFHX2 SP5 PLAG1 | 2.32e-07 | 908 | 97 | 14 | 19274049 |
| Pubmed | 4.18e-07 | 6 | 97 | 3 | 16201967 | ||
| Pubmed | SP1 SP3 WT1 E4F1 RLF SALL2 SMARCA2 SMARCA4 ZFHX2 PLAG1 KLF17 KAT6B | 6.89e-07 | 709 | 97 | 12 | 22988430 | |
| Pubmed | Loss of Rearranged L-Myc Fusion (RLF) results in defects in heart development in the mouse. | 3.90e-06 | 38 | 97 | 4 | 27930960 | |
| Pubmed | Synphilin-1 attenuates mutant LRRK2-induced neurodegeneration in Parkinson's disease models. | 7.70e-06 | 2 | 97 | 2 | 26744328 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 8670841 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 10825178 | ||
| Pubmed | HPV8 activates cellular gene expression mainly through Sp1/3 binding sites. | 7.70e-06 | 2 | 97 | 2 | 31299490 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 23163725 | ||
| Pubmed | Combined gene dosage requirement for SWI/SNF catalytic subunits during early mammalian development. | 7.70e-06 | 2 | 97 | 2 | 23076393 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 25538045 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 15576411 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 15240517 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 26564006 | ||
| Pubmed | SMARCA4/SMARCA2-deficient Carcinoma of the Esophagus and Gastroesophageal Junction. | 7.70e-06 | 2 | 97 | 2 | 33027072 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 23872584 | ||
| Pubmed | Robust hematopoietic specification requires the ubiquitous Sp1 and Sp3 transcription factors. | 7.70e-06 | 2 | 97 | 2 | 31164147 | |
| Pubmed | Alterations of the SWI/SNF chromatin remodelling subunit-BRG1 and BRM in hepatocellular carcinoma. | 7.70e-06 | 2 | 97 | 2 | 23088494 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 20333683 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 34812766 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 17681019 | ||
| Pubmed | Endothelial Sp1/Sp3 are essential to the effect of captopril on blood pressure in male mice. | 7.70e-06 | 2 | 97 | 2 | 37735515 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 26807725 | ||
| Pubmed | Targeting of BRM Sensitizes BRG1-Mutant Lung Cancer Cell Lines to Radiotherapy. | 7.70e-06 | 2 | 97 | 2 | 30478150 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 15951564 | ||
| Pubmed | Transcription factors Sp1 and Sp3 regulate basal transcription of the human IRF-3 gene. | 7.70e-06 | 2 | 97 | 2 | 22464952 | |
| Pubmed | The SWI/SNF ATPases Are Required for Triple Negative Breast Cancer Cell Proliferation. | 7.70e-06 | 2 | 97 | 2 | 25808524 | |
| Pubmed | Sp1 trans-activation of cell cycle regulated promoters is selectively repressed by Sp3. | 7.70e-06 | 2 | 97 | 2 | 8845379 | |
| Pubmed | Antagonistic roles for BRM and BRG1 SWI/SNF complexes in differentiation. | 7.70e-06 | 2 | 97 | 2 | 19144648 | |
| Pubmed | Regulation of LRRK2 promoter activity and gene expression by Sp1. | 7.70e-06 | 2 | 97 | 2 | 27004687 | |
| Pubmed | High expression of SMARCA4 or SMARCA2 is frequently associated with an opposite prognosis in cancer. | 7.70e-06 | 2 | 97 | 2 | 29391527 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 37634210 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 21248046 | ||
| Pubmed | Sp1 and Sp3 activate transcription of the human dopamine transporter gene. | 7.70e-06 | 2 | 97 | 2 | 15816870 | |
| Pubmed | Sp family transcription factors regulate expression of rat D2 dopamine receptor gene. | 7.70e-06 | 2 | 97 | 2 | 9628590 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 8208605 | ||
| Pubmed | The nuclear abundance of transcription factors Sp1 and Sp3 depends on biotin in Jurkat cells. | 7.70e-06 | 2 | 97 | 2 | 14608051 | |
| Pubmed | A Brg1 null mutation in the mouse reveals functional differences among mammalian SWI/SNF complexes. | 7.70e-06 | 2 | 97 | 2 | 11163203 | |
| Pubmed | Transcriptional specificity of human SWI/SNF BRG1 and BRM chromatin remodeling complexes. | 7.70e-06 | 2 | 97 | 2 | 12620226 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 27039070 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 29848589 | ||
| Pubmed | Differentiation-dependent and cell-specific regulation of the hIGFBP-1 gene in human endometrium. | 7.70e-06 | 2 | 97 | 2 | 9329821 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 14766015 | ||
| Pubmed | Differential preimplantation regulation of two mouse homologues of the yeast SWI2 protein. | 7.70e-06 | 2 | 97 | 2 | 9603422 | |
| Pubmed | Hemogen/BRG1 cooperativity modulates promoter and enhancer activation during erythropoiesis. | 7.70e-06 | 2 | 97 | 2 | 35297980 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 23276717 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 27097303 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 28038711 | ||
| Pubmed | Proinflammatory stimuli engage Brahma related gene 1 and Brahma in endothelial injury. | 7.70e-06 | 2 | 97 | 2 | 23963727 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 12493776 | ||
| Pubmed | Heterozygous Mutations in SMARCA2 Reprogram the Enhancer Landscape by Global Retargeting of SMARCA4. | 7.70e-06 | 2 | 97 | 2 | 31375262 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 17075831 | ||
| Pubmed | An Sp1/Sp3 binding polymorphism confers methylation protection. | 7.70e-06 | 2 | 97 | 2 | 18725933 | |
| Pubmed | Loss of SWI/SNF Chromatin Remodeling Alters NRF2 Signaling in Non-Small Cell Lung Carcinoma. | 7.70e-06 | 2 | 97 | 2 | 32855269 | |
| Pubmed | Downregulation of SWI/SNF chromatin remodeling factor subunits modulates cisplatin cytotoxicity. | 7.70e-06 | 2 | 97 | 2 | 22721696 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 18508913 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 11719516 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 19437621 | ||
| Pubmed | DNA binding drives the association of BRG1/hBRM bromodomains with nucleosomes. | 7.70e-06 | 2 | 97 | 2 | 28706277 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 21092585 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 26551623 | ||
| Pubmed | Transcriptional control of human CD2AP expression: the role of Sp1 and Sp3. | 7.70e-06 | 2 | 97 | 2 | 21604172 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 19458193 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 12192045 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 34289068 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 34518526 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 32312722 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 26356327 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 20969766 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 12566296 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 31406271 | ||
| Pubmed | Co-regulation of transcription by BRG1 and BRM, two mutually exclusive SWI/SNF ATPase subunits. | 7.70e-06 | 2 | 97 | 2 | 29273066 | |
| Pubmed | LMTK2-mediated phosphorylation regulates CFTR endocytosis in human airway epithelial cells. | 7.70e-06 | 2 | 97 | 2 | 24727471 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | ZNF384 ZNF280C ZBTB9 SMARCAD1 ZNF711 RLF WIZ ZNF451 SMARCA4 BOD1L1 | 7.97e-06 | 608 | 97 | 10 | 36089195 |
| Pubmed | 9.34e-06 | 15 | 97 | 3 | 28737171 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 1.09e-05 | 497 | 97 | 9 | 36774506 | |
| Pubmed | 1.12e-05 | 104 | 97 | 5 | 9205841 | ||
| Pubmed | 1.66e-05 | 18 | 97 | 3 | 24025402 | ||
| Pubmed | Thymosin beta 4 is dispensable for murine cardiac development and function. | 1.66e-05 | 18 | 97 | 3 | 22158707 | |
| Pubmed | 1.91e-05 | 407 | 97 | 8 | 12693553 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 18417714 | ||
| Pubmed | Transcriptional regulation of BACE1, the beta-amyloid precursor protein beta-secretase, by Sp1. | 2.31e-05 | 3 | 97 | 2 | 14701757 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 15118068 | ||
| Pubmed | Modulation of Bone Morphogenetic Protein (BMP) 2 gene expression by Sp1 transcription factors. | 2.31e-05 | 3 | 97 | 2 | 17317039 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 11850421 | ||
| Pubmed | DNA damage sensitivity of SWI/SNF-deficient cells depends on TFIIH subunit p62/GTF2H1. | 2.31e-05 | 3 | 97 | 2 | 30287812 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 36759621 | ||
| Pubmed | Sp1/3 and NF-1 mediate basal transcription of the human P2X1 gene in megakaryoblastic MEG-01 cells. | 2.31e-05 | 3 | 97 | 2 | 16529657 | |
| Pubmed | Predictive value of Sp1/Sp3/FLIP signature for prostate cancer recurrence. | 2.31e-05 | 3 | 97 | 2 | 23028678 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 19306294 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 15482850 | ||
| Pubmed | Structural and functional characterization of the mouse tescalcin promoter. | 2.31e-05 | 3 | 97 | 2 | 20540995 | |
| Pubmed | Transcriptional regulation of the human CD97 promoter by Sp1/Sp3 in smooth muscle cells. | 2.31e-05 | 3 | 97 | 2 | 18329191 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 20974858 | ||
| Pubmed | Histone deacetylase inhibition is associated with transcriptional repression of the Hmga2 gene. | 2.31e-05 | 3 | 97 | 2 | 12799440 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 16672217 | ||
| Pubmed | Transcription of the LAT gene is regulated by multiple binding sites for Sp1 and Sp3. | 2.31e-05 | 3 | 97 | 2 | 18343609 | |
| Interaction | HDAC1 interactions | RABEP2 SP1 SP3 GAPVD1 ERC1 ZNF507 ZBTB9 RNF40 SMARCAD1 E4F1 RLF WIZ KIF15 CEP250 SMARCA2 SMARCA4 ASCC3 HECTD1 | 4.95e-06 | 1108 | 97 | 18 | int:HDAC1 |
| Interaction | PHF21A interactions | 6.06e-06 | 343 | 97 | 10 | int:PHF21A | |
| Interaction | KDM1A interactions | GAPVD1 ERC1 ZNF280C ZNF507 ZBTB9 RNF40 SMARCAD1 GREB1L RLF ZBTB39 SALL2 WIZ KIF15 ZNF451 SMARCA2 ASCC3 | 1.02e-05 | 941 | 97 | 16 | int:KDM1A |
| Interaction | WHAMMP3 interactions | 2.38e-05 | 119 | 97 | 6 | int:WHAMMP3 | |
| Interaction | CCDC110 interactions | 3.79e-05 | 14 | 97 | 3 | int:CCDC110 | |
| Interaction | PCM1 interactions | CENPE ERC1 ZNF280C CEP290 CCDC66 KIF15 CEP250 PIBF1 COG5 CFAP97 | 4.58e-05 | 434 | 97 | 10 | int:PCM1 |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF438 ZNF384 SP1 SP3 ZNF507 WT1 ZBTB9 ZNF407 E4F1 ZNF236 ZXDA ZNF260 ZNF711 RLF ZBTB39 SALL2 WIZ ZNF451 ZFHX2 SP5 PLAG1 KLF17 | 8.39e-16 | 718 | 62 | 22 | 28 |
| GeneFamily | Zinc fingers C2H2-type|Sp transcription factors | 3.18e-06 | 9 | 62 | 3 | 755 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 5.25e-04 | 46 | 62 | 3 | 622 | |
| GeneFamily | X-linked mental retardation|RNA helicases | 6.24e-04 | 11 | 62 | 2 | 1168 | |
| GeneFamily | Zinc fingers MYND-type|A-kinase anchoring proteins | 4.43e-03 | 29 | 62 | 2 | 396 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SP3 GAPVD1 CENPE ERC1 ZNF804A RLF SGMS1 TIAM1 ZNF451 SMARCA2 PLCB4 ASCC3 PIBF1 KAT6B COG5 | 5.80e-07 | 856 | 97 | 15 | M4500 |
| Coexpression | LAKE_ADULT_KIDNEY_C16_COLLECTING_SYSTEM_PRINCIPAL_CELLS_CORTEX | 1.44e-05 | 141 | 97 | 6 | M39235 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | SP1 SP3 GAPVD1 CENPE CEP290 HEMGN HMGCR SMARCAD1 ZNF804A ZNF711 RLF TBX18 ZNF451 SPHKAP SMARCA4 CFAP97 | 7.18e-07 | 815 | 96 | 16 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | SPATA7 SP3 PDE3B CENPE ERC1 CEP290 FHOD3 HMGCR SMARCAD1 NMNAT3 ZNF711 CCDC66 KIF15 OSGEPL1 PPP1R16B BOD1L1 PLCB4 DBR1 | 1.09e-06 | 1060 | 96 | 18 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | SP1 SP3 GAPVD1 CENPE CEP290 WT1 HEMGN ZNF711 GREB1L RLF ZNF451 SPHKAP SMARCA4 CFAP97 | 1.49e-05 | 804 | 96 | 14 | gudmap_developingGonad_e12.5_ovary_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | SPATA7 SP3 PDE3B CENPE ERC1 CEP290 FHOD3 HMGCR SMARCAD1 ZNF804A NMNAT3 ZNF711 CCDC66 KIF15 OSGEPL1 PPP1R16B BOD1L1 PLCB4 DBR1 | 1.59e-05 | 1414 | 96 | 19 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 2.18e-05 | 186 | 96 | 7 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 8.40e-05 | 311 | 96 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#5_top-relative-expression-ranked_1000 | 9.11e-05 | 233 | 96 | 7 | gudmap_developingGonad_e12.5_ovary_k5_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_500 | 1.14e-04 | 417 | 96 | 9 | gudmap_developingGonad_e11.5_ovary + mesonephros_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | PDE3B CENPE CEP290 FHOD3 SMARCAD1 RLF SAFB KIF15 ASCC3 PIBF1 | 1.47e-04 | 532 | 96 | 10 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | PDE3B CENPE CEP290 FHOD3 HMGCR SMARCAD1 ZNF711 PLEK2 CCDC66 KIF15 OSGEPL1 SUPV3L1 BOD1L1 DBR1 PIBF1 CFAP97 | 1.54e-04 | 1257 | 96 | 16 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | PDE3B DENND4A CENPE CEP290 FHOD3 NBEA SAFB CCDC66 KIF15 FGD4 KAT6B | 1.79e-04 | 654 | 96 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.55e-07 | 197 | 97 | 7 | 7e93a97b5ac5ae2f77a4b3141082a1463fed00dd | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.03e-06 | 183 | 97 | 6 | b5ede5a0048c585b73c00e88aeddbcaf669347b1 | |
| ToppCell | Control-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 3.54e-06 | 188 | 97 | 6 | 88b3415e33db81726dd29c1f50c886e057af50a0 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 3.88e-06 | 191 | 97 | 6 | 5d24022cec293bc8d9e978ae99a109e660bb8f83 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 3.88e-06 | 191 | 97 | 6 | 73dae4cdea86aec62393ad7303dc7375a6b3fc86 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.00e-06 | 192 | 97 | 6 | 0bb06738e1c3ec0c044a7ee61f6cf1d4781fb53c | |
| ToppCell | Control-Endothelial-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.12e-06 | 193 | 97 | 6 | aff0649c73c634bc6ff0dc7759b4693a9236bf05 | |
| ToppCell | Control-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.12e-06 | 193 | 97 | 6 | c5f9fe03e64c211d4bcd4959e5b32f14841e336a | |
| ToppCell | Control-Endothelial-Endothelial-Gen_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.12e-06 | 193 | 97 | 6 | e1d546165dcc2392f540162206852c4717d7306f | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.24e-06 | 194 | 97 | 6 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.50e-06 | 196 | 97 | 6 | 6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0 | |
| ToppCell | COVID-19_Mild-PLT_4|COVID-19_Mild / Disease Group and Platelet Clusters | 4.77e-06 | 198 | 97 | 6 | 3d8c33dba759df0974aeb2b9a6b5167ae7a18e1f | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 4.91e-06 | 199 | 97 | 6 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 4.91e-06 | 199 | 97 | 6 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | IPF-Epithelial-Ionocyte|IPF / Disease state, Lineage and Cell class | 2.64e-05 | 160 | 97 | 5 | d65d19f4fae60836bfd4303a1bb7de34e9d83e35 | |
| ToppCell | IPF-Epithelial-Ionocyte|World / Disease state, Lineage and Cell class | 2.72e-05 | 161 | 97 | 5 | f1cd5c938cdc08ad8995371b72493850a6cf277a | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.98e-05 | 164 | 97 | 5 | 2a230ea066decb798a0e6f2b96c7608c8e608031 | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.98e-05 | 164 | 97 | 5 | d02d39edd0bfef5a53b814ec6d5f026d41253218 | |
| ToppCell | 11.5-Airway-RBC-RBC|Airway / Age, Tissue, Lineage and Cell class | 3.06e-05 | 165 | 97 | 5 | 8618b2c5659aa70c7c9d6e51a227ac612b4ad17b | |
| ToppCell | 11.5-Airway-RBC|Airway / Age, Tissue, Lineage and Cell class | 3.06e-05 | 165 | 97 | 5 | 46042340a373adaf1c439b2301e02fbae3e31a4f | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_11|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.15e-05 | 166 | 97 | 5 | b1bebcbe17386cb102b11d551e62d46156ce0c68 | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_11|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.25e-05 | 167 | 97 | 5 | e44743b20a7435c579d8e999ddc4ca119d6753f2 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 3.63e-05 | 171 | 97 | 5 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.74e-05 | 172 | 97 | 5 | d354424c1f861b6607dfd63b9724f4c237b30275 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Endothelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.17e-05 | 176 | 97 | 5 | 27e5115fae5f0f63b333bc99fbf6a6d4c9182c46 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.17e-05 | 176 | 97 | 5 | 327a3e81b724252e36d786de92a3ffd721ea6d7b | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.40e-05 | 178 | 97 | 5 | c20f050344a2e120e685e2a7fe36c6dfc1dc37b6 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ionocyte|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.64e-05 | 180 | 97 | 5 | 8af8b4af2dc72223ac71fc027e0d4280c5dd81f8 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.76e-05 | 181 | 97 | 5 | 9d782ba5cf5a172cb4f447763fc50e5b13ef7dd9 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.76e-05 | 181 | 97 | 5 | aa233b652921848af2257cc3687a7a09c3acfb67 | |
| ToppCell | wk_20-22-Hematologic-Meg-ery-Definitive_erythroblast|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.89e-05 | 182 | 97 | 5 | 0c77ef4556c1d1512ebe9077df858b28f9e38dd5 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.89e-05 | 182 | 97 | 5 | eb138aa1dca9373f1586600f258df06dcf56d81f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.28e-05 | 185 | 97 | 5 | d602a9b35e86e6f2a14a58e40fc4fb97f5fa3b08 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.28e-05 | 185 | 97 | 5 | bdd2e6cb20294b39a9d856004bf57ba69cf877e2 | |
| ToppCell | facs-Aorta-Heart-3m-Endothelial-nan|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.56e-05 | 187 | 97 | 5 | df0279b7e94e26f5541b0e2a0ce56befa96ec8ca | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.70e-05 | 188 | 97 | 5 | b2d68a32314e9b099ed74d974079ad96359d1ae3 | |
| ToppCell | facs-Heart-LV-18m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.70e-05 | 188 | 97 | 5 | ed11e26ff4ef3d6314b5f5734062519b9aa285c1 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.70e-05 | 188 | 97 | 5 | 789d1be574e693d7bdd488f3c72c6df788e47b47 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.70e-05 | 188 | 97 | 5 | 63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68 | |
| ToppCell | facs-Heart-LV-18m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.70e-05 | 188 | 97 | 5 | e5a8ca4613ab0bf1584b9e78959adf41d0bf379f | |
| ToppCell | facs-Heart-LV-18m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.70e-05 | 188 | 97 | 5 | 0fc3a6562e6895f6fe7a93397eae842a75c60c93 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.99e-05 | 190 | 97 | 5 | 2e88e366d377d74deb53a4ea870973ce5c6532e8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.99e-05 | 190 | 97 | 5 | 0028f886c789ba238c031eae5d96acaed4af8c25 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.99e-05 | 190 | 97 | 5 | 0e9847d7f49b2236b8a191e1a7df37556351ba9e | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 6.15e-05 | 191 | 97 | 5 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.15e-05 | 191 | 97 | 5 | 5020fe6c3452e7fab57847f5043d28ebbc5aa381 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.30e-05 | 192 | 97 | 5 | 04f5a2e3dd6beff027b89d66eefdd92036e041af | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.30e-05 | 192 | 97 | 5 | 0aeb5351275c0a91151ea2d52b2cdde172da6731 | |
| ToppCell | Entopeduncular-Neuronal|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 6.30e-05 | 192 | 97 | 5 | 4c35e5c28a40b439044797ba1f06cb7c36b2a8de | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.30e-05 | 192 | 97 | 5 | c07d7b40b2aa4eb27ac85801c014a656e2fd01dc | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.46e-05 | 193 | 97 | 5 | e09387af84d2a0a526e54d4793e6e06c6739db53 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.46e-05 | 193 | 97 | 5 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 | |
| ToppCell | MS-mDC1|MS / Condition, Cell_class and T cell subcluster | 6.46e-05 | 193 | 97 | 5 | 4d08ebf555954d6a873a4b4c4d661dc5dd8a5bcb | |
| ToppCell | MS-mDC1-|MS / Condition, Cell_class and T cell subcluster | 6.46e-05 | 193 | 97 | 5 | ce873f20b93e3b57c9385ee10d4becebe32ada06 | |
| ToppCell | Control-Myeloid-cDC2|Myeloid / Disease state, Lineage and Cell class | 6.46e-05 | 193 | 97 | 5 | 4cb938c346cc32ec122d11e6b9f25db20e0f7ff6 | |
| ToppCell | Fetal_29-31_weeks-Epithelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.46e-05 | 193 | 97 | 5 | a0ca3231992f14abcf1a6129573bace320e89d2a | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.61e-05 | 194 | 97 | 5 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.61e-05 | 194 | 97 | 5 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-05 | 195 | 97 | 5 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.78e-05 | 195 | 97 | 5 | ed5f772c82d4dfd1c8735224446ec9feae3fb8c2 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-05 | 195 | 97 | 5 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.94e-05 | 196 | 97 | 5 | 7e5addaa844e66f8160e05858c341866a80aed23 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.94e-05 | 196 | 97 | 5 | 1522958a92e0126326a9f0d9fb1c5b5c50b001ea | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.94e-05 | 196 | 97 | 5 | 49cc0a2b9739abad61dff7292ea0b14d28ff35c4 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.94e-05 | 196 | 97 | 5 | 1c8294014713684b50885e638668f2ce75f357f0 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 7.11e-05 | 197 | 97 | 5 | 6b6504c47c309bac4f790e2f372d454bbdea49e8 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.11e-05 | 197 | 97 | 5 | bf10727fbe90b71d2ac60a11711e5f0701b3799d | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 7.46e-05 | 199 | 97 | 5 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | Mild/Remission-B_intermediate-0|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 7.46e-05 | 199 | 97 | 5 | 592111591f0f6816fc56620cb555eb48dabf0758 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.46e-05 | 199 | 97 | 5 | 2dc33804f6691d7c9682e6c9b885e945fb97fc36 | |
| ToppCell | LPS_IL1RA|World / Treatment groups by lineage, cell group, cell type | 7.64e-05 | 200 | 97 | 5 | a02fa5b3c4723a6eaa3c685588666c710478dd25 | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.64e-05 | 200 | 97 | 5 | 105c67e4f5eff036013d655c8e8ac577d32dae2e | |
| ToppCell | LPS-IL1RA-Unknown-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.29e-04 | 118 | 97 | 4 | aefad0b35aff980b6a2a98057735442e8a65ab04 | |
| ToppCell | LPS-IL1RA-Unknown|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.29e-04 | 118 | 97 | 4 | 6cb4063b83f867b782080ce5b1199b51bb277f2a | |
| ToppCell | LPS-IL1RA-Unknown-Endothelial-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.61e-04 | 125 | 97 | 4 | 2938a1d62afe1e0a3abba5eb92f07b886cc0accd | |
| ToppCell | facs-Heart-Unknown-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.55e-04 | 141 | 97 | 4 | 4aa4b3476dc5abefbd348353cfe711cd5fe3d52f | |
| ToppCell | facs-Heart-Unknown-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.55e-04 | 141 | 97 | 4 | e40c6f1b7fbaa46b3eaa55f1b37ef360b04370a8 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.62e-04 | 142 | 97 | 4 | 819e983688d126d89a71abc03d72525cc759a347 | |
| ToppCell | facs-Heart-Unknown-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-04 | 142 | 97 | 4 | 759fbbd15b4fb313bd6269b7f087edafebd530ef | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-like-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.62e-04 | 142 | 97 | 4 | 5690eee2ce1ecd02e34eac4193578bd13c4228b9 | |
| ToppCell | P03-Hematopoietic-Erythroid|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.77e-04 | 144 | 97 | 4 | 2ee6a834860eac7ed004f366ab4fc38c4b80c905 | |
| ToppCell | P03-Hematopoietic-Erythroid-enucleate_erythrocyte|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.77e-04 | 144 | 97 | 4 | 9fa63904389f4d7163db22ea85ab721d8f6e8d99 | |
| ToppCell | ASK454-Epithelial-Type_2|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.99e-04 | 12 | 97 | 2 | f8ea75314b9fa2bdc57564cad9640893a47f0340 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-hematologic-hematopoietic_progenitor-hematopoietic_stem_cell|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.15e-04 | 149 | 97 | 4 | e99b7cd3728ce76b365526734c2e7f845b2e62c8 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-hematologic-hematopoietic_progenitor|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.15e-04 | 149 | 97 | 4 | 6a28dd4530ed411747fdfe743db138a1b5547ed7 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-E|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.23e-04 | 150 | 97 | 4 | c3ad5fa41eb636a5d691c0268c0f1c32cd0de658 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-E-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.23e-04 | 150 | 97 | 4 | 78b8029e71d26f336a46274c8afef3435bf536b9 | |
| ToppCell | normal_Lung-Myeloid_cells-Undetermined|normal_Lung / Location, Cell class and cell subclass | 3.32e-04 | 151 | 97 | 4 | 23b6cf9a36ad0e937f69c75921bddd305a9a526c | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c11-GNLY|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.40e-04 | 152 | 97 | 4 | 669d8f12fdb110ed72f4e5348b7b5350144a061c | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_memory_T_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.48e-04 | 153 | 97 | 4 | 64d0f37d7af9b76234f683379e3689771f71fe70 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.48e-04 | 153 | 97 | 4 | d6526d17826470534b766df144c74e73eb83fdad | |
| ToppCell | COVID-19_Mild-Neu_0|COVID-19_Mild / 5 Neutrophil clusters in COVID-19 patients | 3.51e-04 | 63 | 97 | 3 | 1ab77b6f098686bc168427159282bbf3538d4292 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.57e-04 | 154 | 97 | 4 | 71ffc23a2e02e27cabbdbeaa622e59e9f4a4cd9d | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.57e-04 | 154 | 97 | 4 | ec920cae12ea1d14b6c973f6e903f895f80e3c50 | |
| ToppCell | E16.5-samps-Endothelial-Immature_fetal_endothelial-Matrix_Endothelial|E16.5-samps / Age Group, Lineage, Cell class and subclass | 3.57e-04 | 154 | 97 | 4 | 928f49839b046b90c2f942458f3e365ddc4e0bc9 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.57e-04 | 154 | 97 | 4 | 46155f36d3983f637b55d7525b675c8828f6ab2e | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_11|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.66e-04 | 155 | 97 | 4 | fab281db4c275d51240b122be78713c839ba5a95 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.66e-04 | 155 | 97 | 4 | 8fdda4e3657ac56188ae88ed3caf145f4d9d1567 | |
| ToppCell | facs-Lung-EPCAM-3m-Endothelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.66e-04 | 155 | 97 | 4 | 0e942609d3e060f1e589fee5997fc6299f3d18bc | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.75e-04 | 156 | 97 | 4 | dd41ed918b07fa248da458a629b3c53cb7ea8764 | |
| Computational | Neighborhood of NF2 | 7.87e-05 | 302 | 51 | 8 | GCM_NF2 | |
| Disease | fatty acid measurement, linoleic acid measurement | 6.45e-05 | 68 | 93 | 4 | EFO_0005110, EFO_0006807 | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 9.77e-05 | 5 | 93 | 2 | C3281201 | |
| Disease | opportunistic bacterial infectious disease (implicated_via_orthology) | 3.49e-04 | 9 | 93 | 2 | DOID:0050340 (implicated_via_orthology) | |
| Disease | Drug habituation | 4.89e-04 | 115 | 93 | 4 | C0013170 | |
| Disease | Drug abuse | 4.89e-04 | 115 | 93 | 4 | C0013146 | |
| Disease | Prescription Drug Abuse | 4.89e-04 | 115 | 93 | 4 | C4316881 | |
| Disease | Substance-Related Disorders | 4.89e-04 | 115 | 93 | 4 | C0236969 | |
| Disease | Drug Use Disorders | 4.89e-04 | 115 | 93 | 4 | C0013222 | |
| Disease | Drug Dependence | 4.89e-04 | 115 | 93 | 4 | C1510472 | |
| Disease | Substance Dependence | 4.89e-04 | 115 | 93 | 4 | C0038580 | |
| Disease | Substance Use Disorders | 4.89e-04 | 115 | 93 | 4 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 4.89e-04 | 115 | 93 | 4 | C0029231 | |
| Disease | Substance abuse problem | 5.06e-04 | 116 | 93 | 4 | C0740858 | |
| Disease | phospholipids in very small VLDL measurement | 5.66e-04 | 51 | 93 | 3 | EFO_0022300 | |
| Disease | triglycerides to total lipids in very large VLDL percentage | 6.33e-04 | 53 | 93 | 3 | EFO_0022340 | |
| Disease | cholesteryl esters to total lipids in large VLDL percentage | 7.44e-04 | 56 | 93 | 3 | EFO_0022250 | |
| Disease | Coffin-Siris syndrome | 7.49e-04 | 13 | 93 | 2 | C0265338 | |
| Disease | Mental Retardation, X-Linked Nonsyndromic | 7.49e-04 | 13 | 93 | 2 | C3501611 | |
| Disease | Hyperlipoproteinemia Type IIb | 7.49e-04 | 13 | 93 | 2 | C1704417 | |
| Disease | free cholesterol to total lipids in medium VLDL percentage | 7.84e-04 | 57 | 93 | 3 | EFO_0022284 | |
| Disease | triglycerides to total lipids in medium VLDL percentage | 1.05e-03 | 63 | 93 | 3 | EFO_0022335 | |
| Disease | cholesterol to total lipids in medium VLDL percentage | 1.05e-03 | 63 | 93 | 3 | EFO_0022239 | |
| Disease | Hyperlipoproteinemia Type IIa | 1.15e-03 | 16 | 93 | 2 | C0745103 | |
| Disease | Leber congenital amaurosis | 1.15e-03 | 16 | 93 | 2 | cv:C0339527 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 1.26e-03 | 148 | 93 | 4 | C0279702 | |
| Disease | coronary artery disease | FLT1 WDR33 CFTR WT1 HEMGN HMGCR SMARCA4 LRRC7 COG5 ADGRL3 PMFBP1 | 1.33e-03 | 1194 | 93 | 11 | EFO_0001645 |
| Disease | Hypercholesterolemia, Familial | 1.45e-03 | 18 | 93 | 2 | C0020445 | |
| Disease | nephrotic syndrome | 1.48e-03 | 71 | 93 | 3 | EFO_0004255 | |
| Disease | free cholesterol to total lipids in small VLDL percentage | 1.74e-03 | 75 | 93 | 3 | EFO_0022287 | |
| Disease | vital capacity | ZNF438 FLT1 ERC1 SYNE1 WT1 C16orf96 TBX18 SMARCA2 PLAG1 PIBF1 PMFBP1 | 1.75e-03 | 1236 | 93 | 11 | EFO_0004312 |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 1.84e-03 | 276 | 93 | 5 | EFO_0004612, EFO_0020943 | |
| Disease | non-high density lipoprotein cholesterol measurement | 1.87e-03 | 713 | 93 | 8 | EFO_0005689 | |
| Disease | Malignant neoplasm of breast | ZNF438 FLT1 IDO1 SYNE1 WT1 ANKRD30A BOD1L1 LRRC7 HSD11B1 KAT6B | 2.06e-03 | 1074 | 93 | 10 | C0006142 |
| Disease | Leber Congenital Amaurosis | 2.18e-03 | 22 | 93 | 2 | C0339527 | |
| Disease | free cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 2.57e-03 | 86 | 93 | 3 | EFO_0008595, EFO_0020945 | |
| Disease | unipolar depression, schizophrenia | 2.81e-03 | 25 | 93 | 2 | EFO_0003761, MONDO_0005090 | |
| Disease | pre-eclampsia (is_implicated_in) | 2.81e-03 | 25 | 93 | 2 | DOID:10591 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LKNVKFMNHVKHHLE | 316 | Q86YH2 | |
| LLATKNSHLRHIEHM | 416 | O75150 | |
| LDHRHKQKVLHDTMD | 331 | Q9P2B7 | |
| LITVSKILHHKMLHS | 941 | P13569 | |
| VLMAHVEVKHSDAVH | 846 | Q9HAR2 | |
| AREHLELLKHMHTVG | 231 | Q7Z2E3 | |
| TIDIHFLERKMQHHL | 1351 | Q9BXX3 | |
| EDHLAVHKHKHEMTL | 21 | P17544 | |
| LNLFHDDIHHVRKSM | 126 | P28845 | |
| KDDQDMHALGKKHTH | 756 | Q53SF7 | |
| MHALGKKHTHENVKE | 761 | Q53SF7 | |
| HVLPIEKHISHFMHK | 341 | Q7Z401 | |
| MHVHHLESLLEQKEK | 341 | Q8IUD2 | |
| LQMAELVTTHKCLHH | 361 | Q9H5N1 | |
| HDIATTLQHLHMIDK | 936 | Q8WYB5 | |
| HHMEAHALTIRLTNK | 146 | Q9H4B0 | |
| KLNMLSIDHLTDHKS | 61 | P14902 | |
| HVDKLEHHSTQMQEL | 746 | Q9NS87 | |
| DMVHLVHARKAQHLA | 876 | Q86VF7 | |
| HSFVHMEHEKAVLLL | 1506 | Q96NW7 | |
| HLVKSHMIHNRSKIN | 861 | P04035 | |
| MVKLDIHTLAHHLKQ | 1 | Q14C86 | |
| LCKALVHMHDKSIVH | 461 | Q9C098 | |
| KEHEQKMQLLLHHFK | 1171 | Q86VH2 | |
| LMHHLTENHKIWKEI | 1061 | Q13370 | |
| HHEMKETNEQKLHKI | 196 | Q96M96 | |
| IHLNVLELMQKHIHS | 441 | Q5S007 | |
| MHKLHFLHSDLALRN | 256 | Q8IWU2 | |
| HAMEGISHLHLLVVK | 1536 | Q9C091 | |
| MDLGKDQSHLKHHQT | 1 | Q9BXL5 | |
| HKHDVIMKSQLRHKS | 316 | Q96T49 | |
| AHEIHVLEKHTNMNL | 241 | Q15165 | |
| HADHRSTLTKKMHIQ | 1196 | Q8NFC6 | |
| KLHQSVTKAIHALME | 586 | Q9UP83 | |
| HLVHKDTLHSAMAVV | 156 | Q9ULT8 | |
| HGILEHIHMAELKKV | 31 | A6NNT2 | |
| MEKFRAVLDLHVKHH | 1 | Q5R3K3 | |
| EMEPKSHHTLKIAHQ | 1526 | O15078 | |
| HMTLKERHGELQDHK | 1851 | Q9BV73 | |
| HKQSLLHHVCTMVVE | 1121 | Q2V2M9 | |
| HKKHITAENMKSSLV | 136 | A2RUB6 | |
| EFMRSDHLKQHQKTH | 351 | Q5JT82 | |
| HLHVKFAALMQHQAK | 226 | Q9UK59 | |
| ILKAHMVTHSSRKDH | 206 | Q66K89 | |
| ERATLKKHMLLAHHQ | 951 | Q9Y467 | |
| EELKIVHMHLKEHQE | 1721 | Q02224 | |
| VHMHLKEHQETIDKL | 1726 | Q02224 | |
| EKDHLHSVMVHLQQE | 921 | Q8TBY8 | |
| LRHSIDEVHHKNMII | 676 | Q2M3C7 | |
| HMAHKSEQILKAASL | 36 | Q6ZWK4 | |
| MRSDHLAKHVKTHQN | 366 | Q6BEB4 | |
| HAKEHSTMQKLHCTQ | 946 | Q15147 | |
| MKNHHCKLTQVLNTH | 856 | P51531 | |
| MMLDILEVLLKHHQH | 881 | Q9H4L7 | |
| EILQDHHKQLMQIKH | 8586 | Q8NF91 | |
| HHKQLMQIKHELLES | 8591 | Q8NF91 | |
| LSHMQLHHLDPKTFK | 191 | Q8N135 | |
| MLDQHHTDLILKLHA | 106 | Q96NR3 | |
| LGHKRKVEIMHTHSL | 776 | Q8NFP9 | |
| SMKAEANALHHKHDK | 246 | Q8NC44 | |
| MKNHHCKLTQVLNTH | 886 | P51532 | |
| FKQKEHLLEHMSQHR | 276 | O95785 | |
| HNITKLIKMSETHKL | 671 | Q8IYB8 | |
| MRSDHLSKHIKTHQN | 696 | P08047 | |
| HLHKTELHGKMISVE | 466 | Q15424 | |
| LKDMRKDEIGHILHH | 1151 | Q8N3C0 | |
| DHLTRHMKKSHNQEL | 226 | Q6DJT9 | |
| AHKENKLHLQQHVSM | 191 | Q86WT6 | |
| SKELLLKVMESHHQH | 121 | Q96PP4 | |
| TDMNTHIHQVHKEKS | 766 | Q9Y4E5 | |
| HISLHRIVDKMHDSN | 126 | Q9NYT0 | |
| QHTRIHSKMHTETIK | 301 | Q8TF68 | |
| NLVEHKKMHTGEKSH | 41 | Q3ZCT1 | |
| NSVSHLHKMKKAAID | 1211 | Q9C0A1 | |
| HLDVAIKTMNKVASH | 1216 | Q13009 | |
| FNKLKHHLMEQHNIE | 1421 | Q13129 | |
| ELDDQGHIILHSMHK | 251 | O95935 | |
| MRSDHLAKHIKTHQN | 691 | Q02447 | |
| HEKHHTLLKEKMLTS | 231 | Q8N0X2 | |
| ILVKMHSKHSENSLL | 691 | Q8WXW3 | |
| KLSHLQMHSRKHTGE | 336 | P19544 | |
| TLKMEHHLEAHKNGH | 66 | Q86VZ5 | |
| HIKQNKHLEEEKMRH | 396 | Q9P0W8 | |
| KHLEEEKMRHLLHVL | 401 | Q9P0W8 | |
| HLLEKHMAVHQSLED | 521 | O15060 | |
| KLKHHLTEHMKTHAG | 421 | Q96C00 | |
| SKDLESHMIHHCKTR | 681 | Q8TCN5 | |
| KHQLKMHLLTHSSSQ | 281 | P98168 | |
| KRATHLKEHMQTHQA | 1696 | Q9UL36 | |
| HILLQHMKDTHKPGE | 396 | Q8ND82 | |
| LEKHAESHMQQPKEH | 201 | Q9C0G0 | |
| LATLHAHKNTVMEVK | 281 | Q9C0J8 | |
| GSKEHSHMLQKVQEH | 2826 | O15050 | |
| MTELKILTHIGHHLN | 876 | P17948 | |
| SEKNQHIMRHHKEAL | 746 | Q9Y462 | |
| HHILMHLTEKAQEVT | 121 | Q92748 | |
| STHMKLHHGENRLKK | 551 | Q7Z4V0 | |
| QKHHQEEIIHKLAMQ | 71 | Q8NFP0 | |
| KLCQHHHMEKTKESE | 601 | Q7Z570 | |
| LHLKAILAHDEHMAQ | 571 | Q8IYS2 | |
| METVKVLRHHHSKLL | 91 | Q96T66 |